{"transactions":[{"id":2808799,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-04T22:00:21.000Z","date":"2021-03-02","kind":"exercise","acquired":false,"shares":5195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 1/4th of the total shares on January 16, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":82874,"derivative":{"exercise_price":0.6,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":5195},"source":{"system":"sec-edgar","filing":"0001209191-21-017869","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121017869/doc4.xml","form_type":"4"}},{"id":2808798,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-04T22:00:21.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":40800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests as to 1/48th of the total shares on April 2, 2021 and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":40800,"derivative":{"exercise_price":60,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":40800},"source":{"system":"sec-edgar","filing":"0001209191-21-017869","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121017869/doc4.xml","form_type":"4"}},{"id":2808797,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-04T22:00:21.000Z","date":"2020-12-28","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 1/4th of the total shares on January 16, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":88069,"derivative":{"exercise_price":0.6,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-21-017869","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121017869/doc4.xml","form_type":"4"}},{"id":2808796,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2021-03-04T22:00:21.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":2900,"price":63.5155,"value":184194.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $63.13 to $63.99 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":21351,"source":{"system":"sec-edgar","filing":"0001209191-21-017869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121017869/doc4.xml","form_type":"4"}},{"id":2808795,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2021-03-04T22:00:21.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":2295,"price":62.4625,"value":143351.4375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $62.00 to $62.93 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":24251,"source":{"system":"sec-edgar","filing":"0001209191-21-017869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121017869/doc4.xml","form_type":"4"}},{"id":2808794,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2021-03-04T22:00:21.000Z","date":"2021-03-02","kind":"exercise","acquired":true,"shares":5195,"price":0.6,"value":3117.0,"ownership":{"direct":true},"balance_after":26546,"source":{"system":"sec-edgar","filing":"0001209191-21-017869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121017869/doc4.xml","form_type":"4"}},{"id":2808793,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2021-03-04T22:00:21.000Z","date":"2020-12-28","kind":"sale","acquired":false,"shares":149,"price":58.73,"value":8750.77,"ownership":{"direct":true},"balance_after":21351,"source":{"system":"sec-edgar","filing":"0001209191-21-017869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121017869/doc4.xml","form_type":"4"}},{"id":2808792,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2021-03-04T22:00:21.000Z","date":"2020-12-28","kind":"exercise","acquired":true,"shares":8000,"price":0.6,"value":4800.0,"ownership":{"direct":true},"balance_after":21500,"source":{"system":"sec-edgar","filing":"0001209191-21-017869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121017869/doc4.xml","form_type":"4"}},{"id":3002890,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-20T20:52:20.000Z","date":"2020-10-19","kind":"exercise","acquired":false,"shares":1503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vested as to 3/48th of the total shares on January 22, 2019, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":70386,"derivative":{"exercise_price":2.19,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":1503},"source":{"system":"sec-edgar","filing":"0001209191-20-055378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/doc4.xml","form_type":"4"}},{"id":3002889,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-20T20:52:20.000Z","date":"2020-10-19","kind":"exercise","acquired":false,"shares":30497,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 1/4th of the total shares on January 16, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":96069,"derivative":{"exercise_price":0.6,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":30497},"source":{"system":"sec-edgar","filing":"0001209191-20-055378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/doc4.xml","form_type":"4"}},{"id":3002888,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-20T20:52:20.000Z","date":"2020-10-16","kind":"exercise","acquired":false,"shares":5851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 1/4th of the total shares on January 16, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":126566,"derivative":{"exercise_price":0.6,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":5851},"source":{"system":"sec-edgar","filing":"0001209191-20-055378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/doc4.xml","form_type":"4"}},{"id":3002887,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-10-20T20:52:20.000Z","date":"2020-10-19","kind":"sale","acquired":false,"shares":7225,"price":38.4202,"value":277585.945,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $38.19 to $38.90 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001209191-20-055378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/doc4.xml","form_type":"4"}},{"id":3002886,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-10-20T20:52:20.000Z","date":"2020-10-19","kind":"sale","acquired":false,"shares":24775,"price":37.6419,"value":932578.0725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $37.18 to $38.10 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20725,"source":{"system":"sec-edgar","filing":"0001209191-20-055378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/doc4.xml","form_type":"4"}},{"id":3002885,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-10-20T20:52:20.000Z","date":"2020-10-19","kind":"exercise","acquired":true,"shares":1503,"price":2.19,"value":3291.57,"ownership":{"direct":true},"balance_after":45500,"source":{"system":"sec-edgar","filing":"0001209191-20-055378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/doc4.xml","form_type":"4"}},{"id":3002884,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-10-20T20:52:20.000Z","date":"2020-10-19","kind":"exercise","acquired":true,"shares":30497,"price":0.6,"value":18298.2,"ownership":{"direct":true},"balance_after":43997,"source":{"system":"sec-edgar","filing":"0001209191-20-055378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/doc4.xml","form_type":"4"}},{"id":3002883,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-10-20T20:52:20.000Z","date":"2020-10-16","kind":"sale","acquired":false,"shares":5851,"price":40.0003,"value":234041.7553,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $40.00 to $40.02 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001209191-20-055378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/doc4.xml","form_type":"4"}},{"id":3002882,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-10-20T20:52:20.000Z","date":"2020-10-16","kind":"exercise","acquired":true,"shares":5851,"price":0.6,"value":3510.6,"ownership":{"direct":true},"balance_after":19351,"source":{"system":"sec-edgar","filing":"0001209191-20-055378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/doc4.xml","form_type":"4"}},{"id":3008271,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-13T21:43:37.000Z","date":"2020-10-13","kind":"exercise","acquired":false,"shares":1649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to 1/4th of the total shares on January 16, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":132417,"derivative":{"exercise_price":0.6,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":1649},"source":{"system":"sec-edgar","filing":"0001209191-20-054703","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120054703/doc4.xml","form_type":"4"}},{"id":3008270,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-10-13T21:43:37.000Z","date":"2020-10-13","kind":"sale","acquired":false,"shares":1649,"price":40,"value":65960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001209191-20-054703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120054703/doc4.xml","form_type":"4"}},{"id":3008269,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-10-13T21:43:37.000Z","date":"2020-10-13","kind":"exercise","acquired":true,"shares":1649,"price":0.6,"value":989.4,"ownership":{"direct":true},"balance_after":15149,"source":{"system":"sec-edgar","filing":"0001209191-20-054703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120054703/doc4.xml","form_type":"4"}},{"id":3124097,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-06-03T20:57:14.000Z","date":"2020-06-01","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 3/48th of the total shares on January 22, 2019, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":71889,"derivative":{"exercise_price":2.19,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-034096","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120034096/doc4.xml","form_type":"4"}},{"id":3124096,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-06-03T20:57:14.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":1230,"price":27.4809,"value":33801.507,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $27.40 to $27.55 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001209191-20-034096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120034096/doc4.xml","form_type":"4"}},{"id":3124095,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-06-03T20:57:14.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":7875,"price":26.9106,"value":211920.975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $26.39 to $27.38 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14730,"source":{"system":"sec-edgar","filing":"0001209191-20-034096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120034096/doc4.xml","form_type":"4"}},{"id":3124094,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-06-03T20:57:14.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":10895,"price":25.8205,"value":281314.3475,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $25.39 to $26.36 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":22605,"source":{"system":"sec-edgar","filing":"0001209191-20-034096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120034096/doc4.xml","form_type":"4"}},{"id":3124093,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-06-03T20:57:14.000Z","date":"2020-06-01","kind":"exercise","acquired":true,"shares":20000,"price":2.19,"value":43800.0,"ownership":{"direct":true},"balance_after":33500,"source":{"system":"sec-edgar","filing":"0001209191-20-034096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120034096/doc4.xml","form_type":"4"}},{"id":3135165,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-05-26T21:58:42.000Z","date":"2020-05-22","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to 1/4th of the total shares on January 16, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":134066,"derivative":{"exercise_price":0.6,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-20-032149","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120032149/doc4.xml","form_type":"4"}},{"id":3135164,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-05-26T21:58:42.000Z","date":"2020-05-22","kind":"sale","acquired":false,"shares":7500,"price":30,"value":225000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001209191-20-032149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120032149/doc4.xml","form_type":"4"}},{"id":3135163,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-05-26T21:58:42.000Z","date":"2020-05-22","kind":"exercise","acquired":true,"shares":7500,"price":0.6,"value":4500.0,"ownership":{"direct":true},"balance_after":21000,"source":{"system":"sec-edgar","filing":"0001209191-20-032149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120032149/doc4.xml","form_type":"4"}},{"id":3135162,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-05-26T21:57:08.000Z","date":"2020-03-31","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested as to 1/4th of the total shares on January 16, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":141566,"derivative":{"exercise_price":0.6,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-20-032146","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120032146/doc4a.xml","form_type":"4/A","original_submission_date":"2020-04-15"}},{"id":3135161,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-05-26T21:57:08.000Z","date":"2019-12-20","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested as to 1/4th of the total shares on January 16, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":149066,"derivative":{"exercise_price":0.6,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-20-032146","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120032146/doc4a.xml","form_type":"4/A","original_submission_date":"2020-04-15"}},{"id":3176513,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-15T23:33:12.000Z","date":"2020-03-31","kind":"exercise","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested as to 1/4th of the total shares on January 16, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":141566,"derivative":{"exercise_price":0.6,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-20-024546","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120024546/doc4.xml","form_type":"4"}},{"id":3176512,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-15T23:33:12.000Z","date":"2019-12-20","kind":"exercise","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested as to 1/4th of the total shares on January 16, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":149066,"derivative":{"exercise_price":0.6,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-20-024546","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120024546/doc4.xml","form_type":"4"}},{"id":3176511,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-04-15T23:33:12.000Z","date":"2020-03-31","kind":"exercise","acquired":true,"shares":7500,"price":0.6,"value":4500.0,"ownership":{"direct":true},"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001209191-20-024546","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120024546/doc4.xml","form_type":"4"}},{"id":3176510,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Common Stock","published_at":"2020-04-15T23:33:12.000Z","date":"2019-12-20","kind":"exercise","acquired":true,"shares":6000,"price":0.6,"value":3600.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-20-024546","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120024546/doc4.xml","form_type":"4"}},{"id":3194378,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":141801,"kind":"person","name":"Liau Gene","position":1,"cik":"0001780082","reported_name":"Liau Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Research & Preclinical Dev"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-26T22:04:37.000Z","date":"2020-03-25","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48th of the total shares on April 25, 2020 and then 1/48th of the total shares vest monthly thereafter, subject to reporting person's continued service to the issuer through each vesting date."}],"balance_after":42000,"derivative":{"exercise_price":20.25,"expiration_date":"2030-03-24","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001209191-20-021317","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120021317/doc4.xml","form_type":"4"}}]}